48 / 112
46
WFSBP 2015
Scientific Programme
|
Tuesday, 16 June 2015
T10: D
epression
: B
asic
/ C
linical
TG-03
WFSBP Treatment Guidelines
11:00–12:30
MC 3 Room
Guidelines on Depression: Globalization or localization
Chair:
Michael Bauer, Germany
Co-Chair: Raymond W. Lam, Canada
TG-03-001
WFSBP guidelines for unipolar depression
Emanuel Severus, Germany
TG-03-002
Guidelines for major depressive disorder in Korea
Kang Seob Oh, Republic of Korea
TG-03-003
Global guidelines for psychiatrists, local guideline for ge
neral practitioners–MDD guidelines in Taiwan
Chia-Yih Liu, Taiwan
TG-03-004
CANMAT depression guidelines: The next generation of
progress
Raymond W. Lam, Canada
T41: S
exual
D
isorders
: B
asic
/ C
linical
TG-04
WFSBP Treatment Guidelines
15:00–16:30
Skalkotas Hall
Task Force on Paraphilic Disorders: Paraphilia treatment
for adults and adolescents
Chair:
Florence Thibaut, France
Co-Chair: Peer Briken, Germany
TG-04-001
The proposed diagnostic criteria of paraphilic disorders
for ICD-11
Peer Briken, Germany
TG-04-002
WFSBP treatment guidelines on paraphilias
John M. W. Bradford, Canada
TG-04-003
Ethical considerations of hormonal treatment of paraphilic
disorders or sex offenders
Paul Cosyns, Belgium
T7: C
hildhood
& A
dolescent
D
isorders
: B
asic
/ C
linical
D-01
Debate
11:00–12:30
Trianti Hall
Are children overmedicated?
Chair:
Joseph Biederman, USA
Proponent: Maria Nobile, Italy
Opponent: Robert Post, USA
T1: A
ddictive
D
isorders
WS-18
Workshop
16:30–18:00
Trianti Hall
Treating opioid dependence: The future of treatment
tailoring and managing risk for patients on substitute
opioid therapies
Chair:
Jacqueline Hudson, Canada
Co-Chairs: Brittany B. Dennis, Canada
Monica Bawor, Canada
WS-18-001
The GENetics of Opioid Addiction (GENOA) study: An in-
troduction to epidemiologic studies in addiction research
Jacqueline Hudson, Canada
WS-18-002
Risk factors for treatment response among patients with
opioid dependence: Understanding the evidence
Monica Bawor, Canada
WS-18-003
What is the best treatment for opioid addiction? Evi-
dence-based practice in addiction medicine
Brittany B. Dennis, Canada
T24: N
europhysiology
WS-06
Workshop
16:30–18:00
Skalkotas Hall
Transcranial magnetic stimulation studies of neurophy
siology, neuroplasticity, and neurocognition in psychia
tric disorders
Chair:
Paul Croarkin, USA
Co-Chair: Zafiris J. Daskalakis, Canada
WS-06-001
Overview of transcranial magnetic stimulation studies in
severe psychiatric disorders
Zafiris Daskalakis, Canada
WS-06-002
A review of the use of repetitive Transcranial Magnetic
Therapy in the treatment of chronic pain and borderline
personality disorder
Shirlene Sampson, USA
WS-06-003
rTMS studies of neurocognition in schizophrenia
Stephanie Ameis, Canada
A. Voineskos, Z. Daskalakis, D. Blumberger
WS-06-004
The neurochemistry of TMS: Magnetic resonance spec-
troscopy studies
John D. Port, USA